Answers to your questions about the VenaFlux Solutions : Frequently Asked Questions (FAQs)


- Oct 22
- 4 min
The rate of platelet activation determines thrombus size and structure at arterial shear

- Oct 16
- 4 min
EMT status of circulating breast cancer cells and impact of fluidic shear stress – By Jin et al., 20

- Oct 9
- 3 min
New insights into prothrombotic state of post-COVID syndrome patients

- Sep 25
- 4 min
Cardiovascular: Stents; Drug Eluting Stents; Platelet Adhesion

- Sep 20
- 3 min
Chronic platelet activation contributes to Alzheimers Disease and its progression


- Aug 14
- 2 min
VenaFlux Solutions for Thrombosis assay : Technical Specifications

- Jul 31
- 2 min
Understanding Cellix's Microfluidic Hydrodynamic Focusing Set-up

- Jun 26
- 4 min
Bacteriology: E. Coli; Adhesion; Biofilm Formation

- May 23
- 2 min
Getting started with Cellix's Vena8 Glass Coverslip Biochips

- May 15
- 5 min
Inflammation: Leukocyte Adhesion; Quantifying Adhesion; Inhibition, Stimulation

- May 8
- 1 min
VenaDeltaY Biochips: for dual flow / dual injection of samples

- May 1
- 3 min
Respiratory: Eosinophil; Adhesion Assay; Asthma

- Apr 24
- 3 min
VenaT4 Biochip: for cell migration, transmigration, invasion and chemotaxis studies


- Apr 17
- 3 min
Vena8 Fluoro+ Biochip: for cell receptor–ligand studies with conditions mimicking physiological flow

- Apr 11
- 3 min
Getting started with Cellix's Vena8 Endothelial+ biochip

- Mar 20
- 4 min
Respiratory: Eosinophil; Inflammation; Adhesion Assay

- Mar 13
- 3 min
Intravenous abciximab as a rescue therapy in stroke patients


- Feb 27
- 4 min
VenaFlux Solutions for Thrombosis assay : How does it work?

- Feb 20
- 3 min
VenaFlux for thrombosis: Installation and training guide